0001123292-16-002562.txt : 20160803
0001123292-16-002562.hdr.sgml : 20160803
20160803142152
ACCESSION NUMBER: 0001123292-16-002562
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160801
FILED AS OF DATE: 20160803
DATE AS OF CHANGE: 20160803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mack Randall
CENTRAL INDEX KEY: 0001602336
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 161803382
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-08-01
0001588972
Recro Pharma, Inc.
REPH
0001602336
Mack Randall
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
0
1
0
0
Senior VP, Development
Common Stock
2016-08-01
4
M
0
6100
A
8100
D
Common Stock
2016-08-01
4
F
0
2546
9.70
D
5554
D
On August 1, 2016, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 6,100 performance-based restricted stock units, which were converted into 6,100 shares of common stock on a one-for-one basis.
/s/ Donna Nichols, attorney-in-fact
2016-08-03